Eyevance Pharmaceuticals established with Zerviate licensing agreement

Former Sun Pharmaceutical leaders Jerry St. Peter and Jason Werner have formed Eyevance Pharmaceuticals, a new company focusing on ophthalmic pharmaceuticals, according to a press release.The company, founded this month, recently entered into an exclusive licensing agreement with Nicox for U.S. commercialization of Zerviate (cetirizine ophthalmic solution 0.24%), the first topical formulation of cetirizine approved for ocular itching associated with allergic conjunctivitis.

Full Story →